ArticleWorld journal of surgical oncology2025
The association between PSCA gene polymorphism and hepatocellular carcinoma risk.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe current study aims to determine whether prostate stem cell antigen (PSCA) gene polymorphism confers a risk for hepatocellular carcinoma (HCC). The aim is to find out the novel markers for predicting HCC risk and provide an early warning mechanism for the population susceptible to HCC.
methodsA case-control study was used to select 160 HCC patients who were admitted to People's Hospital of Ningxia Hui Autonomous Region between May 2021 and April 2024 as the case group, and 280 healthy adults matching the gender and age of the case group were collected as the normal control group. PSCA gene polymorphism was detected using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). At the same time, whether the interaction of gene and smokers affects polymorphism is also investigated.
resultsSignificant associations were found at the rs2294008 and rs2976392 loci of PSCA gene (P < 0.05). However, there were no significant differences at the rs1045531 or rs2978974 loci (P > 0.05). All HCC patients were divided into smokers and non-smokers. The final results did not show any significant difference in genotype frequency between the two groups.
conclusionThe PSCA rs2294008 and rs2976392 polymorphisms contribute to an increased risk of HCC and serve as two novel markers for predicting HCC risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.